CYNAPSUS THERAPEUTICS INC's ticker is CYNA and the CUSIP is 23257Y859. A total of 61 filers reported holding CYNAPSUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 4.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $24,000 | +71.4% | 600 | -27.5% | 0.01% | +62.5% |
| Q2 2016 | $14,000 | +40.0% | 828 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $10,000 | -9.1% | 828 | +18.3% | 0.01% | 0.0% |
| Q4 2015 | $11,000 | 0.0% | 700 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $11,000 | +37.5% | 700 | +40.0% | 0.01% | +40.0% |
| Q2 2015 | $8,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 313,524 | $5,070,000 | 2.94% |
| Aisling Capital LLC | 975,191 | $15,769,000 | 2.77% |
| First Light Asset Management, LLC | 302,194 | $4,886,000 | 2.41% |
| PURA VIDA INVESTMENTS, LLC | 194,461 | $3,102,000 | 1.77% |
| Ghost Tree Capital, LLC | 175,000 | $2,830,000 | 1.27% |
| DAFNA Capital Management LLC | 44,824 | $707,000 | 0.70% |
| Broadfin Capital, LLC | 586,117 | $9,052,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 188,930 | $3,059,000 | 0.39% |
| Opaleye Management Inc. | 29,000 | $469,000 | 0.23% |
| J. Goldman & Co LP | 135,000 | $2,183,000 | 0.19% |